Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ewa Laszuk"'
Autor:
Zita Pöstényi, Urszula Karczmarczyk, Veronika Kovács-Haász, Piotr Garnuszek, Agnieszka Sawicka, Renata Mikolajczak, Lajos Balog, András Polyák, Ewa Laszuk, Wioletta Wojdowska
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 35:558-562
Background: This work aimed to evaluate the influence of two chelators: DOTA(SCN) and DOTA(NHS) on radioimmunotherapy using 177Lu-DOTA-Rituximab preparations in murine lymphoma xenograft models. Su...
Publikováno v:
Zeszyty Problemowe Postępów Nauk Rolniczych. :23-29
Publikováno v:
Current radiopharmaceuticals. 15(1)
Background: The choice of mice strain can significantly influence the physiological distribution and may lead to an inadequate assessment of the radiopharmaceutical properties. Objective: This work aims to present how the legal requirements that appl
Autor:
Wioletta, Wojdowska, Urszula, Karczmarczyk, Lajos, Balog, Agnieszka, Sawicka, Zita, Pöstényi, Veronika, Kovács-Haász, András, Polyák, Ewa, Laszuk, Renata, Mikołajczak, Piotr, Garnuszek
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 35(8)
Autor:
Justyna Pijarowska-Kruszyna, Piotr Garnuszek, Urszula Karczmarczyk, Antoni Jaron, Marcin Radzik, Ewa Laszuk, Renata Mikolajczak
Publikováno v:
Nuclear Medicine Review. 20:88-94
BACKGROUND: Technetium Tc99m Exametazime (99mTc-HMPAO) is currently used as a radiopharmaceutical for determining regional cerebral blood flow and for the labelling of autologous leucocytes for infection and inflammation imaging. The HMPAO ligand exi
Autor:
Urszula, Karczmarczyk, Wioletta, Wojdowska, Renata, Mikołajczak, Michał, Maurin, Ewa, Laszuk, Piotr, Garnuszek
Publikováno v:
Iranian journal of pharmaceutical research : IJPR. 17(4)
This work presents a comparative biological evaluation of